Business Context and Reporting Period
This Form 6-K filing by GlaxoSmithKline plc covers the period ending November 28, 2006. The report serves as a notification of transactions involving Directors, Persons Discharging Managerial Responsibility, or Connected Persons regarding Ordinary Shares of the registrant.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This document is a regulatory disclosure of specific share transactions rather than a financial performance report.
Material Changes
The filing details a change in the number of Ordinary Share American Depositary Receipts (ADRs) held by the GlaxoSmithKline US Retirement Savings Plan ("the Plan").
- Date of Movement: November 23, 2006
- Previous Holding: 17,444,497 ADRs
- New Holding: 17,429,386 ADRs
- Average Price: $52.00
- Reason: A movement in the fund.
Management Commentary and Risks
The Plan is a discretionary fund where all employees or former employees of GlaxoSmithKline plc and its subsidiaries are potential beneficiaries. Two directors, Dr. J P Garnier and Dr. M M Slaoui, are noted as potentially interested in the shares held in the fund in the same manner as other employees. The notification was made in accordance with Disclosure Rule 3.1.4R(1)(b). No specific risks, contingencies, or unusual items regarding the company's operations were disclosed in this text.
Investor Verification Points
- Verify the impact of the fund movement on the total share count held by the US Retirement Savings Plan.
- Confirm the potential interest of Directors Dr. J P Garnier and Dr. M M Slaoui in the fund's holdings.
- Note that this filing does not contain financial performance data; refer to Form 20-F for comprehensive financial metrics.